Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Evidence: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2015 (DIBASY) trial

version: 20; Last updated: 2023-12-06 17:43:24+0000

Profiles: ComparativeEvidence, SingleStudyEvidence

url: https://fevir.net/resources/Evidence/47695

identifier: FEvIR Object Identifier/47695

name: ComparativeEvidence_Mean_difference_in_HbA1c_between_Surgery_and_Medical_Lifestyle_groups_in_Mingrone_2015_DIBASY_trial

title: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2015 (DIBASY) trial

status: Active

date: 2022-05-29 11:07:10+0000

author: Brian S. Alper:

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence CommunicationComparativeEvidence
*Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence CommunicationSingleStudyEvidence

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

relatesTo

type: Derived From

target: https://diabetesjournals.org/care/article/39/6/861/29305/Metabolic-Surgery-in-the-Treatment-Algorithm-for

relatesTo

type: Cite As

target:

ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2015 (DIBASY) trial [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 47695. Revised 2022-05-29. Available at: https://fevir.net/resources/Evidence/47695. Computable resource at: https://fevir.net/resources/Evidence/47695.

description:

Mean HbA1c at 60 months in Mingrone 2015 was 6.55% in Surgery group (n = 38) and 6.9% in Medical/Lifestyle group (n = 15), mean difference -0.35% (95% CI -0.69% to -0.01%)

variableDefinition

description:

53 patients aged 30-60 years with BMI of 35 or more and a history of T2DM lasting at least 5 years

variableRole: Population

observed: StudyGroup: DIBASY Trial Enrollment Group

variableDefinition

description:

Roux-en-Y gastric bypass or Biliopancreatic Diversion vs. medical treatment

variableRole: Exposure

comparatorCategory: medical treatment

observed: GroupAssignment: Roux-en-Y gastric bypass or Biliopancreatic Diversion vs. medical treatment

variableDefinition

description:

HbA1c at 60 months

variableRole: Outcome

observed: OutcomeVariable: HbA1c at 60 months

synthesisType: not applicable

studyDesign: randomized assignment

statistic

description:

mean difference -0.35% (95% CI -0.69% to -0.01%)

note:

Mean HbA1c at 60 months in Mingrone 2015 was 6.55% in Surgery group (n = 38) and 6.9% in Medical/Lifestyle group (n = 15)

statisticType: Mean Difference

quantity: -0.35 % (Details: UCUM code% = '%')

SampleSizes

-NumberOfParticipantsKnownDataCount
*5353

AttributeEstimates

-DescriptionTypeLevelRange
*

95% CI -0.69% to -0.01%

Confidence interval0.95-0.69--0.01 %